OABINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABIW
OmniAb, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.69+0.10 (+2.18%)
Close on Oct 19, 2026
- Market cap
- $604.05M
- P/E (TTM)
- –
- Dividend yield
- –
OmniAb, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License and milestone revenue | $28.05M | $19.78M | $9.77M | $12.53M | $13.29M | $15.17M | $13.87M | $6.93M | $7.56M | $8.77M | $20.70M | $50.09M | 72.9% | +111.1% |
| Service revenue | $8.00M | $7.47M | $7.26M | $7.56M | $8.85M | $11.09M | $11.95M | $12.17M | $12.71M | $10.99M | $12.18M | $13.29M | 20.8% | -9.6% |
| xPloration revenue | $1.32M | $766.00K | $754.00K | $724.00K | $650.00K | $42.00K | $0 | – | – | – | – | – | 3.4% | +102.9% |
| Royalty revenue | $1.09M | $931.00K | $878.00K | – | – | – | – | $1.31M | $1.44M | $1.29M | $1.29M | $1.31M | 2.8% | – |
By region
From the segment and revenue-disaggregation notes of OmniAb's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.